David Ipe

Oral oseltamivir treatment of influenza in children

Richard J. Whitley, Frederick G. Hayden, Keith S. Reisinger et al. · The Pediatric Infectious Disease Journal · 2001 · 711 citations

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Edward Gane, Stuart K. Roberts, Catherine AM Stedman et al. · The Lancet · 2010 · 335 citations

Hepatology, Hepatitis C, Viral Hepatitis +9

Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model

Inhye E. Ahn, Xin Tian, David Ipe et al. · Journal of Clinical Oncology · 2020 · 102 citations · Full text

Oral Oseltamivir in Human Experimental Influenza B Infection

Frederick G. Hayden, Lance Jennings, Richard A. Robson et al. · Antiviral Therapy · 2000 · 98 citations

Oral Oseltamivir, Medicine, Immunology +9

Effect of IL28B Genotype on Early Viral Kinetics During Interferon-Free Treatment of Patients With Chronic Hepatitis C

Tom Chu, Rohit Kulkarni, Edward Gane et al. · Gastroenterology · 2012 · 91 citations · Full text

Il28b Genotype, Viral Persistence, Hepatology +11